« BIOTECHNOLOGY
25. Correa HL. Agile Manufacturing as the 21st Century for Improving Manufacturing Competitiveness. In A. Gunasekaran, Agile Manufacturing as the 21st Century for Competitive Strategy. 2001; 3-24. Kidlington, Oxford, UK: Elsevier Science Ltd.
26. Cremer P, Loesch M, Schrader U. Maximizing efficiency in pharma operations. The McKinsey Quarterly - Operations Practice. 2009 April:2-4.
27. D´souza A, Keeling DJ, Phillips RD. Improving Quality in pharma manufacturing. The McKinsey Quarterly - Health CareStrategy. 2007: 1-7
28. D´souza A, Keeling DJ, Phillips RD. Improving Quality in pharma manufacturing. The McKinsey Quarterly - Health CareStrategy. 2007
29. Hayes RH, Schmenner RW. How Should You Organize Manufacturing? Harvard Business Review. 1978; 105-117. Harvard University, Boston, MA, USA
30. Hayes RH, Wheelwright SC, Clark KB. Dynamic Manufacturing - Creating the Learning Organization. Free Press, New York, NY, USA 1988
31. Hayes RH, Pisano G, Upton D, Wheelwright SC. Pursuing the Competitive Edge. Hoboken, NJ, USA: John Wiley & Sons. 2005.
32. Wheelwright SC, Hayes RH. Competing Through Manufacturing. Harvard Business Review , 1985 2-12. Harvard University, Boston, MA,USA.
33. Sieblist C, Ähle M, Pohlscheidt M, Jenzsch, M, Lübbert, A. Insights into Large Scale Cell Culture Reactors: I. Liquid Mixing and Oxygen Supply. Biotechnology Journal 2011; 6:1532-1546
34. Sieblist C, Hägeholz O, Ähle M, Jenzsch M, Pohlscheidt M, Lübbert A. Insights into Large Scale Cell Culture Reactors: II. Gas-Phase Mixing and CO2-Stripping. Biotechnology Journal 2011;6:1547-1556
35. Sieblist C, Jenzsch M, Pohlscheidt M, Lübbert A. Underlying principles Bioreactor Fluid
Dynamics.in Comprehensive Biotechnology, second edition 2011, 6:517-530. In: Murray MooYoung (ed), Comprehensive Biotechnology, Second Edition, Volume 2; pp.47-62:Elsevier
36.
Schäpe S, Lübbert A, Pohlscheidt M, Sieblist C, Jenzsch M. Bioreactor Performance: Insights into Transport Properties of Aerated Stirred Tanks, American Pharmaceutical Review 2012; 15(6): 1-5
37. Pohlscheidt M, Corrales M, Charanyia S, Fallon E, Bruch M, Jenzsch M, Sieblist C. Avoiding Pitfalls During Technology Transfer of Cell Culture Manufacturing Processes in the Pharmaceutical Industry – Mitigating Risk and Optimizing Performance. Pharmaceutical Outsourcing 2013;14(2):34-48
38. Carrondo MJT, Alves PM, Carinhas N, Glassey J, Hesse F, Merten OW, Micheletti M, Noll T, Oliveira R, Reichl U, Staby A, Teixeira AP, Weichert H, Mandenius CF. How can measurement, monitoring, modeling and control advance cell culture in industrial biotechnology? Biotechnol. J. 2012, 7, 1522–1529
39. Schäpe S, Kuprijanov A, Simutis R, Lübbert A, Pohlscheidt M, Jenzsch M. Batch-to-batch reproducibility of fermentation processes by robust operational design and control. Pharmaceutical Bioprocessing 2013;1(3):297-307
40. Pohlscheidt M, Charaniya S, Bork C, Jenzsch M, Nötzel T, Lübbert A. Bioprocess and Fermentation Monitoring, in: The Encyclopedia of Industrial Biotechnology, Bioprocess, Bioseparation and Cell Technology. Editor Flickinger M. 2012; (2):147. John Wiley & Sons, Inc., ISBN 9780470054581
41. Kloth C, Mac lsaaac G, Ghemrenariam H, Arunakumari A. Inoculum Expansion Methods, Recombinant Mammalian Cell Lines. Encyclopedia of Industrial Biotechnology: Bioprocess, Bioseparation and Cell Technology. 2010; 1–30. John Wiley & Sons. Inc.
42. Heidemann R, Mered M, Wang DQ, Gardner B, Zhang C, Michaels J, Henzler HJ, Abbas N, Konstantinov K. A new seed-train expansion method for recombinant mammalian cell lines. Cytotechnology. 2002;38:99–108
43. Pohlscheidt M, Jacobs M, Wolf S, Thiele J, Jockwer A, Gabelsberger J, Jenzsch M, Tebbe H, Burg J. Optimizing Capacity Utilization by Large Scale 3000 L Perfusion in Seed Train Bioreactors. Biotechnol Progress 2013;29(1):222-9
DSM Biologics
Your innovative service & technology partner XD®
Technology
:: Very high-density mammalian processes – 240 million cell/mL
:: Increased bioreactor output & yield per volume 5 – 15 fold :: High & Consistent product quality :: Reduced capital expenditure requirements
Contract Manufacturing Services :: One-stop-shop :: From development to commercial manufacturing :: GMP for all clinical phases & market supply :: Regulatory support :: Global reach
:: 25 years serving the biopharmaceutical market
Tel: +1 973 257 8220 Email:
info.dsmbiologics@dsm.com
www.americanpharmaceuticalreview.com |
| 53
»
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154 |
Page 155 |
Page 156